Cervical intraepithelial neoplasia: Analysis of mRNA profile in the practice of liquid-based cytology


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Subjects and methods. The mRNA expression level of 21 genes (Ki-67, STK-15, CCNB1, CCND1, MYC, MYBL2, P16INK4A, PTEN, BIRC5, BCL2, BAG1, TERT, NDRG1, ESR1, PGR, HER2, GRB7, MGB1, MMP11, CTSL2, and CD68) was determined by quantitative PCR in the material of preservative fluid collection vials after CellPrep PAP test in 59 patients who had been treated at the Russian Research Center of Roentgenology and Radiology in 2015-2016. The test of significance was the results of comparison with subsequent histological examination. Results. Discriminant analysis has established that a combined assessment of ESR1 and MYBL2 mRNA expression levels allows correct classification in 88.24% of cases of CIN2+ changes and in less than 84.0% of cases of histologically confirmed CIN1. The combined assessment of mRNA expression levels of 17 genes (ESR1, MYBL2, CD68, PTEN, CCND1, BCL2, HER2, MMP11, TERT, STK15, P16INK4A, BAG1, CTSL2, KI67, CCNB1, GRB7, and NDRG1) permits differentiation of CIN 2+ and CIN1 or less cases with an accuracy at 98.3%. The coincidence rate of the classification with the data of histological examination was 100.0% for the CIN2+ group and 96.0% for the histologically confirmed CIN1 or less group. Conclusion. It has been shown for the first time that the mRNA expression of a large group of genes can be analyzed by quantitative PCR in the material of CellPrep liquid-based cytology in the PAP test. Assessment of the expression of a panel of 21 genes, which complements the preoperative morphological diagnosis of precancerous processes and cancer of the cervix uteri in the material of liquid-based cytology, allows a high-precision differential diagnosis of 2 clinically important groups, such as the CIN 2+ and CIN1 or less ones (intact epithelium/benign tissue changes of the cervix).

Full Text

Restricted Access

About the authors

Nadezhda Vasilevna Melnikova

Russian Research Center of Roentgenology and Radiology, Ministry of Health of Russia

Email: n_melnikova@list.ru
Ph.D., Leading Researcher of the Laboratory of Immunology, oncocytology and cell therapy in oncology

Vladimir Konstantinovich Bozhenko

Russian Research Center of Roentgenology and Radiology, Ministry of Health of Russia

Email: vbojenko@mail.ru
MD, Head of the Department of Molecular Biology and Experimental Tumor Therapy

Irina Borisovna Antonova

Russian Research Center of Roentgenology and Radiology, Ministry of Health of Russia

Email: iran24@yandex.ru
MD, Head of the Laboratory of prevention, early diagnostics and combination treatment of cancer diseases

Nataliya Aleksandrovna Babaeva

Russian Research Center of Roentgenology and Radiology, Ministry of Health of Russia

Email: natbabaeva@yandex.ru
MD, Leading researcher of Laboratory of prevention, early diagnostics and combined treatments of cancer diseases

Nataliya Yurevna Yarovaya

Russian Research Center of Roentgenology and Radiology, Ministry of Health of Russia

Email: natalya-yarovaya@yandex.ru
Ph.D., Head of the Laboratory of Cytology at the Pathology department

Nataliya Aleksandrovna Bolotina

Russian Research Center of Roentgenology and Radiology, Ministry of Health of Russia

Email: soloma-natali@yandex.ru
Ph.D., Pathologist at the Pathology department

Margarita Vladimirovna Zakharenko

Russian Research Center of Roentgenology and Radiology, Ministry of Health of Russia

Email: zak-margarita@mail.ru
Junior Researcher of the Laboratory of Immunology, oncocytology and cell therapy in oncology

Anna Leonidovna Senchukova

Russian Research Center of Roentgenology and Radiology, Ministry of Health of Russia

Email: asenchukova@gmail.com
Ph.D., Researcher of the Laboratory of Immunology, oncocytology and cell therapy in oncology

Nataliya Borisovna Akopova

Russian Research Center of Roentgenology and Radiology, Ministry of Health of Russia

Ph.D., Obstetrician-gynecologist of the Department of Radiation and instrumental diagnostics of tumor diseases of the reproductive organs

Nataliya Vladimirovna Aleksandrova

Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: alexandrova.ncagip@gmail.com
MD

Olga Vladimirovna Burmenskaya

Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: bourmenska@mail.ru
MD, Senior Researcher of Laboratory molecular genetic factors

Levon Andreevich Ashrafyan

Russian Research Center of Roentgenology and Radiology, Ministry of Health of Russia

MD, Professor, Head of the Department of Early carcinogenesis, prevention, diagnostics and comprehensive treatment of oncological diseases of female reproductive organs

References

  1. Каприн А.Д., Старинский В.В., Петрова Г.В., ред. Злокачественные новообразования в России в 2015 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИРЦ» Минздрава России; 2017. 250с. Available at: http://www.oncology.ru/service/statistics/ malignant_tumors/2015.pdf [Kaprin A.D., Starinsky V.V., Petrova G.V., ed. Malignant neoplasms in Russia in 2015 (morbidity and mortality). Moscow: MNIOI im. P.A. Herzen - branch of FGBU „NIIRTs” of the Ministry of Health of Russia; 2017. 250s. Available at: http://www.oncology.ru/service/ statistics/malignant_tumors/2015.pdf (in Russian)]
  2. Боженко В.К., Кудинова Е.А., Близнюков О.П., Мельникова Н.В., Бурменская О.В. Патент на изобретение RUS 2464570, МПК G01N33/53. Метод диагностики цервикальных интраэпителиальных неоплазий. Заявитель и патентообладатель ФГУ „РНЦРР” Минздравсоцразвития России (RU). № 2010147074/15; Заявлено 19.11.2010; Опубл. 20.10.2012; Бюл. №29. 9с. [Bozhenko V.K., Kudinova E.A., Bliznyukov O.P., Melnikova N.V., Burmenskaya O.V. Patent for invention RUS 2464570, IPC G01N33 / 53. The method of diagnosis of cervical intraepithelial neoplasia. Applicant and patent holder of FGU „RNSRD” of the Ministry of Health and Social Development of Russia (RU). No. 2010147074/15; Declared on 19.11.2010; Publ. 20.10.2012; Bul. №29. 9p. (in Russian)]
  3. Боженко В.К., Ашрафян Л.А., Антонова И.Б., Мельникова Н.В., Бурменская О.Н., Трофимов Д.Ю., Кудинова Е.А., Хунова Л.З., Слонов А.В., Близнюков О.П. Анализ экспрессии генов пролиферации и апоптоза при цервикальных интраэпителиальных неоплазиях и раке шейки матки. Опухоли женской репродуктивной системы. 2011; 4: 72-5. [Bozhenko V.K., Ashrafyan L.A., Antonova I.B., Mel’nikova N.V., Burmenskaya O.N., Trofimov D.Yu., Kudinova E.A., Hunova L.Z., Slonov A.V., Bliznyukov O.P. Analysis of the expression of proliferation and apoptosis genes in cervical intraepithelial neoplasia and cervical cancer. Opuholi zhenskoj reproduktivnoj sistemy. 2011;4:72-75 (in Russian)]
  4. Del Pino M., Svanholm-Barrie C., Torné A., Marimon L., Gaber J., Sagasta A. et al. mRNA biomarker detection in liquid-based cytology: a new approach in the prevention of cervical cancer. Mod. Pathol. 2015; 28(2): 312-20. doi: 10.1038/ modpathol.2014.106.
  5. Wang H.Y., Park S., Kim S., Lee D., Kim G., Kim Y. et al. Use of hTERT and HPV E6/E7 mRNA RT-qPCR TaqMan assays in combination for diagnosing high-grade cervical lesions and malignant tumors. Am. J. Clin. Pathol. 2015; 143(3): 344-51. doi: 10.1309/AJCPF2XGZ2XIQYQX.
  6. Боженко В.К., Васкевич Е.Ф., Трофимов Д.Ю., Бурменская О.В., Кудинова Е.А., Хунова Л.З. Анализ изменения профиля экспрессии генов при гиперпролиферативных заболеваниях шейки матки. Клиническая лабораторная диагностика. 2011; 9: 21. [Bozhenko V.K., Vaskevich E.F., Trofimov D.Yu., Burmenskaya O.V., Kudinova E.A., Hunova L.Z. Analysis of changes in the profile of gene expression in hyperproliferative diseases of the cervix. Klinicheskaya laboratornaya diagnostika. 2011;9: 21 (in Russian)]
  7. Tavassoli F.A., Devilee P., eds. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC; 2003. 432p.
  8. Zhai Y., Bommer G.T., Feng Y., Wiese A.B., Fearon E.R., Cho K.R. Loss of estrogen receptor 1 enhances cervical cancer invasion. Am. J. Pathol. 2010; 177(2): 884-95. doi: 10.2353/ajpath.2010.091166.
  9. Astbury K., McEvoy L., Brian H., Spillane C., Sheils O., Martin C. et al. MYBL2 (B-MYB) in cervical cancer: putative biomarker. Int. J. Gynecol. Cancer. 2011;21(2): 206-12. doi: 10.1097/IGC.0b013e318205759f.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies